Enzymatically Responsive Nanocarriers Targeting PD-1 and TGF-β Pathways Reverse Immunotherapeutic Resistance and Elicit Robust Therapeutic Efficacy.
Journal of Nanobiotechnology（2025）
Key words
Transforming growth factor-β,Immune checkpoint inhibitors,Drug resistance,Polymeric nanoparticles,Tumor microenvironment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined